Australian (ASX) Stock Market Forum

ME1 - Melodiol Global Health

Ok ok
Two Cartons
E90DA657-0D63-41EC-B431-554C59E38257.png
 
Clean missed it
Busy doing other things!!

clear as day volume spike break out to 13.5 c

arrrrh
 

Attachments

  • 2C2DD321-35F1-4A8D-812A-0DFA72568E61.png
    2C2DD321-35F1-4A8D-812A-0DFA72568E61.png
    109.9 KB · Views: 21
Am noticing other cannabis stocks that didn't move yesterday are moving today. EG: IHL, THC etc
Wow, just noticed Credo has a high of 0.24 today already which would have been over 50% up today alone at that point.
This is just nuts.
 
It will consolidate at some value seen as fair by the market.
Right now its seeing some Pump and dump.
I've watched 400k lots bought at a level then sold 2c higher then loaded 3c lower
to buy again.
Rinse and repeat. Volatility is king.
 
CPH is riding on the crest and so is Evarblu.
Recently CPH has raised capital and out of which a substantial to go to everblu.
Who is evarblu - refer to this article on AFR back in 2018 and strong connection with CPH.
"The planned date of issue for 94,736,843 shares under the Placement is 1 April 2021. All of the other issues, being 23,684,211 options to placement participants and 3,600,000 shares to EverBlu will be issued subject to shareholder approval at a future General Meeting. The date of the General meeting set out in this Appendix 3B is indicative only"
In addition to this one - 6% commission. some great gun at the cost of shareholders -
b What fee, commission or other consideration is payable to them for acting as lead manager/broker? EverBlu will earn a 6% cash fee and one million shares per $5 million raised, being the 3,600,000 shares the subject of this Appendix 3B.
19 million dollars raised could imply Everblu potentially to earn 0.06*19/5 M = $228000 fee plus 3.6 million (about) shares for $19 M raised.
 
in a Trading Halt
... placed on the Company’s securities pursuant to ASX Listing Rule 17.1, pending its response to a price query from ASX.
3 days of downward pressure, accelerating today.

Some scuttlebutt in the news, some punters joining the dots, perhaps:
ASIC raids on EverBlu Capital, whose executive chairman, Adam Blumenthal, doubles as non-executive chairman and co-founder at ASX-listed Creso Pharma, and is often seen as the market face for the stock.
There were other raids in connection to the investigation, including on the Gold Coast. The exact nature of the investigation is not known, although ASIC is expected to be keeping an open mind to see what if any evidence turns up in the raids.
 
I’m not sure whether this is innovative, weird or both. The next few months will be telling.

CEO, Mr William Lay said: “We are very excited to become the first ASX-listed cannabis company to launch in The Sandbox metaverse. This follows a considerable amount of hard work, planning and strategy and highlights the Company’s innovative approach to driving marketing and sales across new, borderless channels.


“We expect that the launch will allow for the introduction of Creso Pharma’s brands and products to a wide range of new consumers and potential investors utilising the metaverese to seek the latest and most exciting opportunities.


 
Top